The existence of driver alterations is linked to fast progression. Although a handful of alterations are enriched in CLL in comparison to MBL, both phases share a similar driver composition. (??? "???????????????????????????????????????????????"Duvelisib was the second PI3K inhibitor authorised with the FDA, also depending on a section III randomiz